Korio Videos And Podcasts
-
Inspection Ready IRT And RTSM Audit Trail
4/10/2026
When inspectors ask for RTSM audit data, are you ready? Chuck Harris shares how Korio gives sponsors immediate access—no requests, no delays.
-
Is RTSM Startup Speed The Wrong Success Metric?
4/10/2026
Explore Clinical Trials focus on the study startup timeline and what is controllable at this stage.
-
It Works Great Until Your Protocol Changes
4/10/2026
The CEO of Korio discusses the challenges of change and how Korio's platform addresses every shifting protocols.
-
RTSM Integrations Monitoring Demo
4/10/2026
Explore the Integration Monitor built into the Korio platform in this demonstration.
-
Reducing Human Error With A Blinding Engine
4/10/2026
In this 1-minute clip, see how this RTSM's blinding engine automates the blinding setup process, removing risk before it starts.
-
Is Your Clinical Trial's IRT/RTSM System Stuck In The 90s?
3/25/2026
This clip explores why RTSM tech often trails modern expectations and how ingrained organizational habits keep teams tied to legacy systems that no longer meet today’s clinical trial demands.
-
When It Comes To IRT/RTSM In Your Clinical Trials, Speed Isn't Always A Good Thing
3/25/2026
This clip shows why speed alone isn’t enough in clinical trials, stressing the need for thoughtful design, operational alignment, and long‑term reliability when pressure to move fast rises.
-
How To Make Your Clinical Trial Protocol More IRT/RTSM Friendly?
3/25/2026
Simplifying and standardizing protocol elements strengthens RTSM builds by creating clear, repeatable structures that cut risk and boost reliability across the study lifecycle.
-
Why Your IRT/RTSM Vendor Relationship Matters More Than You Think
3/25/2026
Access how the quality of your RTSM vendor relationship shapes the day‑to‑day experience of clinical teams and why strong collaboration is essential for keeping studies running smoothly under pressure.
-
Focus On RTSM For Your Full Trial Lifecycle
3/25/2026
Reveal why rapid RTSM startup can introduce long‑term risk and highlight the importance of flexibility, thoughtful planning, and strong support during the far more demanding post‑go‑live phase of a clinical trial.